Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings
Purchase of Assets and Related Global Commercialization Rights for Oral 9-cis-Retinol (Zuretinol) for Rare Forms of Childhood Blindness. Clinical Stage Asset...
University Of Washington United States San Francisco Bay David Saperstein Eluminex Biosciences Charles Semba
Source: prnewswire.com